Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology

This review article explores Multiple system atrophy (MSA), a rare and aggressive neurodegenerative disease defined by the buildup of α-synuclein protein. The authors examine the shift toward a two-co...

21 Kesä 22min

This source describes a phase 3 clinical trial investigating the effectiveness of intravenous fosphenytoin for treating sudden, intense flare-ups of trigeminal neuralgia. While standard oral medicatio...

21 Kesä 17min

This medical review examines current pharmacological strategies for migraine prophylaxis, distinguishing between episodic and chronic forms of the condition. The authors evaluate traditional oral ther...

14 Kesä 10min

This randomized, double-blind study investigated the potential for autologous mesenchymal stem cells (MSCs) to repair neurological damage in patients with progressive multiple sclerosis. Using an intr...

7 Kesä 19min

Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment, but they can trigger a wide range of neurological immune-related adverse events (irAE) by disrupting immune tolerance. These co...

31 Touko 20min

This study examines the clinical characteristics and long-term outcomes of anti-KLHL11 encephalitis, a rare paraneoplastic neurologic syndrome primarily affecting middle-aged men. Researchers identifi...

31 Touko 21min

This clinical review highlights frequent diagnostic and therapeutic errors encountered by neurologists when managing sleep disorders. The authors emphasize that chronic insomnia should primarily be tr...

25 Touko 19min

The provided sources detail phase 3 clinical trial results for tavapadon, a novel, once-daily dopamine D1/D5 receptor agonist designed to treat Parkinson disease. In the TEMPO-1 study, fixed doses of ...

24 Touko 16min